— EPA’s ToxCast™ evaluation of the developmental toxicity risk of 1,065 compounds using Stemina’s devTOX quickPredict test (devTOXqP) published in Toxicological Sciences
— devTOXqP is the only human test for assessing a drug or chemical’s potential to cause birth defects in the developing human embryo, providing a better understanding of how they impact maternal and prenatal health and answering the global call to reduce animal testing
MADISON, Wis.–(BUSINESS WIRE)–Recently published results from an evaluation of 1,065 chemical and drug substances using the devTOX quickPredict (devTOXqP) screening platform developed by Stemina Biomarker Discovery, Inc. demonstrated the platform’s ability to predict developmental toxicity in humans with high accuracy using a cell-based test. In a peer-reviewed article published in Toxicological Sciences, scientists from the U.S. Environmental Protection Agency (EPA) reported that Stemina’s devTOXqP test predicted the potential for developmental toxicity in a blinded set of chemicals and drugs from the agency’s ToxCast™ program with an accuracy of 82%, where there was clear evidence of toxicity in humans or in animal studies. The agency’s research suggests that devTOXqP is a useful tool for predicting developmental toxicants in humans and reducing the need for animal testing.
Recent Comments